NEW YORK, NY--(Marketwired - April 25, 2018) - ELUCIDA ONCOLOGY, INC ®, a biotechnology company focused on developing and commercializing a first-in-class, ultra-small nanoparticle platform technology ...

Wyeth's Bob Essner announced recently that he's relinquishing his long-held CEO spot to his longtime number two, Bernard Poussot. Now, Bob's not leaving pharma, or even Wyeth—where he'll serve as ...

Bob Essner - Chairman and CEO. Ladies and gentlemen thank you for standing by. Welcome to the Wyeth Second Quarter Earnings Call. At this time all participants are in a listen-only mode. Later, we ...

The U.S. Food and Drug Administration is starting to act like Pharma's watchdog not lapdog complains Wyeth's outgoing chief executive officer Bob Essner and it's no fair. Not only has it failed to ...

Investors, mindful of the fact that people don't stop getting sick when times are tough, have traditionally viewed pharmaceuticals stocks as a good bet in a weak economy. But these days analysts and ...

Wyeth has announced that Robert Essner will retire as chairman, effective June 27th, 2008. Bernard Poussot, Wyeth’s president and CEO will take over as chairman upon Essner’s departure. “Bob ...

Wyeth announced a series of executive promotions this morning, marking another step in Bernard Poussot's transition as chief executive officer. In August, Wyeth named Poussot to succeed Bob Essner as ...

We can fill in the another line on that always-popular list -- Where Are the Ex-Pharma CEOs Now? This time, the career move involves Bob Essner, who was CEO of Wyeth between 2001 and the end of 2007 ...